Test Code |
Test Name |
U.S. Patent No. |
871 |
BBS1 (BBS) DNA Sequencing Test |
6,962,788 |
|
|
|
872 |
BBS2 (BBS) DNA Sequencing Test |
7,008,782, 6,962,788 |
|
|
|
827 |
ABCC8 (CH) DNA Sequencing Test |
6,054,313 |
|
|
|
876 |
ABCC8 (NDM) DNA Sequencing Test |
6,054,313 |
|
|
|
483 |
AChR/MuSK Reflexive Antibody Test |
7,267,820, 7,732,147 |
|
|
|
179 |
ADmark® Early Onset Alzheimer's Evaluation |
6,117,978 6,194,153, 6,531,586 6,210,919, 6,998,467, 6,485,911, 5,840,540, 5,986,054, 7,846,679, 7,838,247 |
|
|
|
167 |
ADmark® PS-1 DNA Sequencing Test |
6,194,153, 6,210,919, 6,531,586, 6,998,467 |
|
|
|
169 |
ADmark® PS-2 DNA Sequencing Test |
6,485,911, 6,117,978, 5,840,540, 7,838,247 |
|
|
|
178 |
ADmark® Alzheimer's Evaluation |
5,843,779, 5,861,257 6,010,913 6,114,133 |
|
|
|
177 |
ADmark® Phospho-Tau/Total-Tau/Ab42 CSF Analysis & Interpretation (Symptomatic) |
5,843,779, 5,861,257, 6,010,913, 6,114,133 |
|
|
|
493 |
Aprataxin DNA Sequencing Test |
7,119,186, 7,824,860 |
|
|
|
352 |
Ataxia-Telangiectasia (ATM) DNA Deletion Analysis |
5,955,279, 6,951,724, 6,458,536 |
|
|
|
351 |
Ataxia-Telangiectasia (ATM) DNA Sequencing Analysis |
5,955,279, 6,951,724, 6,458,536 |
|
|
|
531 |
Atlastin (SPG3A) DNA Sequencing Test |
7,649,088, 7,108,975, 7,582,425 |
|
|
|
812 |
Autoimmune Polyglandular Syndrome (AIRE) Evaluation |
7,217,806, 7,785,789 |
|
|
|
697 |
Autosomal Dominant Ataxia Evaluation |
5,741,645, 5,840,491, 5,853,995, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,673,535, 6,844,431, 6,855,497, 7,118,893, 7,329,487, 7,585,629, 7,655,401, 7,741,458, 8,247,173, 8,748,096, 8,975,018, 8,163,483 |
|
|
|
653 |
Autosomal Dominant Hereditary Spastic Paraplegia Evaluation |
6,924,126, 7,108,975, 7,582,425, 7,811,762, 7,649,088 |
|
|
|
693 |
Autosomal Recessive Ataxia Evaluation |
7,824,860, 7,119,186 |
|
|
|
887 |
Bardet-Biedl Syndrome Evaluation |
7,008,782, 6,962,788, 7,947,479, 8,129,161 |
|
|
|
837 |
CEL (MODY8) Mutation Analysis |
5,827,683 |
|
|
|
277 |
Co-GM1 Quattro™ |
5,989,829, 5,985,578, 6,077,681, 6,824,999, 6,020,140 |
|
|
|
861 |
COL1A1 (OI) DNA Sequencing Test |
6,265,157 |
|
|
|
696 |
Complete Ataxia Evaluation |
5,741,645, 5,840,491, 5,853,995, 6,150,091, 6,303,307, 6,280,938, 6,514,755, 6,524,791, 6,844,431, 6,673,535, 6,855,497, 7,118,893, 7,119,186, 7,329,487, 7,527,931, 7,585,629, 7,655,401, 7,824,860, 8,163,483 |
|
|
|
353 |
Complete Ataxia-Telangiectasia (ATM) Evaluation |
5,955,279, 6,951,724 |
|
|
|
286 |
Complete Dejerine Sottas Neuropathy |
5,786,927, 727,698, 7,537,899 |
|
|
|
655 |
Complete Hereditary Spastic Paraplegia Evaluation |
6,924,126, 7,108,975, 7,582,425, 7,811,762 |
|
|
|
243 |
Complete HNPP Evaluation |
5,780,223, 5,599,920, 5,306,616 |
|
|
|
147 |
Complete Myotonia Evaluation |
5,955,265, 5,977,333, 6,902,896, 7,442,782 |
|
|
|
126 |
Complete Myotonic Dystrophy Evaluation |
5,955,265, 5,977,333 |
|
|
|
761 |
Complete PKD Evaluation |
6,228,591, 6,031,088, 7,294,465, 7,553,644, 6,916,619, 7,521,190, 7,273,701, 7,083,915, 8,530,161 |
|
|
|
153 |
Complete Rett Syndrome Evaluation |
6,709,817, 7,670,773, 8,637,236 |
|
|
|
573 |
Complete SCN1A Evaluation |
7,078,515 |
|
|
|
215 |
Complete SMA Evaluation (Reflexive) |
6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
|
|
556 |
Complete Tuberous Sclerosis Evaluation |
6,326,483, 6,232,452, 6,548,258 |
|
|
|
819 |
Congenital Hyperinsulinism Evaluation |
6,054,313, 5,723,593 |
|
|
|
245 |
Congenital Hypomyelination Evaluation |
5,876,927 |
|
|
|
329 |
Connexin Related Deafness Evaluation |
5,998,147, 6,485,908, 7,258,975, 8,455,195, 8,143,000 |
|
|
|
133 |
Connexin32 DNA Sequencing Test |
5,691,144, 6,001,576 |
|
|
|
|
|
|
|
143 |
Connexin32 Evaluation |
5,691,144, 6,001,576 |
|
|
|
|
|
|
|
674 |
CSTB (EPM1) Evaluation |
6,432,635 |
|
|
|
|
|
|
|
321 |
Cx26 DNA Sequencing Test |
5,998,147, 6,485,908, 7,258,975, 8,455,195, 8,143,000 |
|
|
|
|
|
|
|
108 |
DM1 DNA Test |
5,955,265, 5,977,333 |
|
|
|
|
|
|
|
110 |
DM2 DNA Test |
6,902,896, 7,442,782 |
|
|
|
|
|
|
|
561 |
Dysferlin Protein Blood Test |
7,172,858 |
|
|
|
|
|
|
|
626 |
Dystonia (DYT1) DNA Test |
6,387,616, 6,921,814 |
|
|
|
|
|
|
|
207 |
Early Onset Myotonia Evaluation |
5,955,265, 5,977,333 |
|
|
|
|
|
|
|
722 |
Early Onset Nephrotic Syndrome Evaluation |
7,105,291, 6,207,811, 6,924,110, 7,388,086, 7,799,529 |
|
|
|
|
|
|
|
881 |
Endocrine Hypertension (HSD11B2) Evaluation |
5,883,240, 5,780,223 |
|
|
|
|
|
|
|
296 |
Entrapment Neuropathy Evaluation |
5,780,223 |
|
|
|
|
|
|
|
187 |
Familial Hemiplegic Migraine Type I (CACNA1A) DNA Test |
5,714,319 |
|
|
|
|
|
|
|
119 |
Friedreich Ataxia DNA Test |
6,150,091 |
|
|
|
|
|
|
|
348 |
Friedreich's Ataxia DNA Sequencing Analysis |
6,150,091 |
|
|
|
|
|
|
|
349 |
Friedreich's Ataxia Profile |
6,150,091 |
|
|
|
|
|
|
|
|
|
|
770 |
Hereditary Interstitial Kidney Disease Assay |
7,781,164, 8,759,001 |
|
|
|
|
|
|
|
802 |
HNF4A (MODY1) DNA Sequencing and Deletion Test |
6,187,533 |
|
|
|
|
|
|
|
717 |
Inherited Focal and Segmental Glomerulosclerosis (FSGS) Evaluation |
6,924,110, 7,388,086, 7,745,597 |
|
|
|
|
|
|
|
874 |
Lipoid CAH (StAR) Evaluation |
5,807,678, 5,872,230 |
|
|
|
|
|
|
|
222 |
LITAF/SIMPLE DNA Sequencing Test |
7,449,291 |
|
|
|
|
|
|
|
811 |
LRP5 (OPPG) DNA Sequencing Test |
6,545,137, 6,555,654, 7,244,577 |
|
|
|
|
|
|
|
821 |
LRP5 Idiopathic Osteoporosis (IOP) DNA Sequencing Test |
6,545,137, 6,555,654, 7244,577 |
|
|
|
|
|
|
|
543 |
LRRK2 DNA Test |
7,544,786, 7,993,841 |
|
|
|
|
|
|
|
145 |
MAG 'Dual Antigen'® Autoantibody Test |
6,599,756, 6,951,763 |
|
|
|
|
|
|
|
223 |
MFN2 DNA Sequencing Test |
7,727,717, 8,206,922, 8,975,020 |
|
|
|
|
|
|
|
885 |
Monogenic Diabetes (MODY) Evaluation |
5,827,683, 6,187,533, 6,274,310 |
|
|
|
|
|
|
|
346 |
Motor Neuropathy Profile - Complete |
6,599,756 6,951,763 , 5,807,705, 6,020,140 6,077,681, 6,824,999 |
|
|
|
|
|
|
|
482 |
MuSK Antibody Test |
7,267,820, 7,732,147 |
|
|
|
|
|
|
|
134 |
Myelin Protein Zero (MPZ) DNA Sequencing Test |
5,876,927 |
|
|
|
|
|
|
|
438 |
NeoCerebellar Degeneration Paraneoplastic Profile with Recombx |
7,329,499, 5,925,526, 5,807,705, 6,387,639, 7,026,450 |
|
|
|
|
|
|
|
4620 |
NeoComplete Paraneoplastic Profile with Recombx |
7,329,499, 5,925,526, 5,807,705, 6,387,639 7,026,450 |
|
|
|
|
|
|
|
4722 |
NeoEncephalitis Paraneoplastic Profile with Recombx |
7,329,499, 5,807,705, 6,387,639, 7,026,450 |
|
|
|
|
|
|
|
882 |
Neonatal Diabetes Mellitus Evaluation |
6,054,313, 5,863,724 |
|
|
|
|
|
|
|
360 |
NeoSeM® Basic Paraneoplastic Profile |
5,925,526, 5,807,705 |
|
|
|
|
|
|
|
436 |
NeoSensory Neuropathy Paraneoplastic Profile with Recombx™ |
7,329,499, 5,807,705 |
|
|
|
|
|
|
|
532 |
NIPA1 (SPG6) DNA Sequencing Test |
7,332,282, 8,518,638 |
|
|
|
|
|
|
|
846 |
Noonan Syndrome (PTPN11) DNA Sequencing Test |
7,335,469 |
|
|
|
|
|
|
|
421 |
Notch3 DNA Sequencing Test |
7,138,234 |
|
|
|
|
|
|
|
730 |
NPHS1 (Nephrin) Sequencing Analysis |
7,799,529, 7,105,291, 6,207,811 |
|
|
|
|
|
|
|
710 |
NPHS2 (Podocin) Sequencing Analysis |
6,924,110, 7,388,086 |
|
|
|
|
|
|
|
300 |
OPMD DNA Test |
6,828,430, 7,364,852 |
|
|
|
|
|
|
|
239 |
Periaxin DNA Sequencing Test |
7,273,698, 7,537,899 |
|
|
|
|
|
|
|
889 |
Pheochromocytoma Evaluation |
6,312,890, 5759,790 |
|
|
|
|
|
|
|
728 |
PKDx® Familial Mutation Evaluation |
6,656,681, 6,228,591, 6,031,088, 7,294,465, 6,485,960, 6,916,619, 7,273,701, 7,083,915, 7,553,644, 7,521,190, 8,530,161 |
|
|
|
|
|
|
|
725 |
PKDx® Sequencing Analysis |
6,656,681, 6,228,591, 6,031,088, 7,294,465, 6,485,960, 7,553,644, 6,916,619, 7,521,190, 7,273,701, 7,083,915, 7,553,644, 7,521,190, 8,530,161 |
|
|
|
|
|
|
|
247 |
PMP22 DNA Sequencing Test |
5,780,223 |
|
|
|
|
|
|
|
131 |
PMP22 Duplication/Deletion DNA Test |
5,780,223 |
|
|
|
|
|
|
|
816 |
Primary Adrenal Insufficiency Evaluation |
7,217,806, 5,869,039, 7,785,789 |
|
|
|
|
|
|
|
639 |
Primary Dystonia Evaluation |
6,387,616, 6,921,814 |
|
|
|
|
|
|
|
122 |
Recombx™ MaTa Autoantibody Test |
6,387,639, 7,026,450 |
|
|
|
|
|
|
|
123 |
Recombx™ CV2 Antibody Test |
7,329,499, 7,183,400 |
|
|
|
|
|
|
|
120 |
Recombx™ Hu Autoantibody Test |
5,807,705 |
|
|
|
|
|
|
|
125 |
Recombx™ Yo Autoantibody Test |
5,925,526 |
|
|
|
|
|
|
|
529 |
REEP1 (SPG31) DNA Sequencing Test |
7,811,762 |
|
|
|
|
|
|
|
142 |
Rett Syndrome (MECP2) DNA Sequencing Test |
6,709,817, 7,670,773, 8,637,236 |
|
|
|
|
|
|
|
148 |
Rett Syndrome (MECP2) Duplication/Deletion Analysis |
6,709,817, 7,670,773, 8,637,236 |
|
|
|
|
|
|
|
371 |
SCA1 DNA Test |
5,834,183, 5,741,645 |
|
|
|
|
|
|
|
387 |
SCA10 DNA Test |
6,855,497 |
|
|
|
|
|
|
|
284 |
SCA13 Select Exon DNA Test |
7,585,629, 8,163,483 |
|
|
|
|
|
|
|
593 |
SCA14 DNA Test |
7,655,401 |
|
|
|
|
|
|
|
672 |
SCA2 Expansion Analysis |
6,673,535, 6,844,431, 8,957,018 |
|
|
|
|
|
|
|
105 |
SCA3 (Machado-Joseph Disease) DNA Test |
5,840,491 |
|
|
|
|
|
|
|
675 |
SCA5 DNA Sequencing Test |
7,527,931 |
|
|
|
|
|
|
|
373 |
SCA6 DNA Test |
7,329,487 |
|
|
|
|
|
|
|
677 |
SCA7 Expansion Analysis |
6,280,938, 6,514,755, 7,118,893 |
|
|
|
|
|
|
|
384 |
SCA8 DNA Test |
6,524,791, 7,741,458, 8,748,096, 8,247,173 |
|
|
|
|
|
|
|
537 |
SCN1A Deletion Test |
7,723,027, 8,288,096 |
|
|
|
|
|
|
|
287 |
SensoriMotor Neuropathy Profile-Complete |
6,599,756 6,951,763 , 5,807,705, 5,985,578, 6,020,140, 6,824,999 |
|
|
|
|
|
|
|
265 |
Sensory Neuropathy Profile |
6,599,756, 6,951,763 5,807,705, 6,020,140, 5,985,578 |
|
|
|
|
|
|
|
263 |
Sensory Neuropathy Profile-xp |
6,599,756, 6,951,763 , 5,807,705, 6,020,140, 5,985,578 |
|
|
|
|
|
|
|
594 |
SETX DNA Sequencing Test |
7,704,691, 8,192,933 |
|
|
|
|
|
|
|
214 |
SMA Plus (Reflexive) |
6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
|
|
|
|
|
|
211 |
SMN DNA Sequencing Test |
6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
|
|
|
|
|
|
530 |
Spastin (SPG4) DNA Sequencing Test |
6,924,126 |
|
|
|
|
|
|
|
444 |
Spinal Muscular Atrophy Carrier Test |
6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
|
|
|
|
|
|
111D |
Spinal Muscular Atrophy Diagnostic Test |
6,080,577, 7,033,752, 8,394,932, 8,962,269 |
|
|
|
|
|
|
|
210 |
Sulfatide Autoantibody Test |
6,020,140, 5,985,578 |
|
|
|
|
|
|
|
804 |
TCF1 (MODY3) DNA Sequencing and Deletion Test |
6,187,533 |
|
|
|
|
|
|
|
805 |
TCF2 (MODY5) DNA Sequencing and Deletion Test |
6,187,533 |
|
|
|
|
|
|
|
712 |
TRPC6 DNA Sequencing Test |
7,745,597 |
|
|
|
|
|
|
|
523 |
TSC Familial Mutation Evaluation |
6,326,483, 6,232,452 |
|
|
|
|
|
|
|
508 |
TSC1 Deletion Analysis |
6,548,258 |
|
|
|
|
|
|
|
521 |
TSC1 DNA Sequencing Test |
6,326,483, 6,548,258 |
|
|
|
|
|
|
|
524 |
TSC2 DNA Deletion Test |
6,232,452 |
|
|
|
|
|
|
|
522 |
TSC2 DNA Sequencing Test |
6,232,452 |
|
|
|
|
|
|
|
858 |
von Hippel Lindau VHL |
5,759,790 |